Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advanced Oncotherapy, Kerecis, Retia Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atossa, Bergenbio, Boehringer, Harbour, Inhibrx, Novavax, Noxxon, Sanofi, Swedish Orphan, Translate.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Brainq, Discerndx, Gore.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aelix, Algernon, Biohaven, Bioventus, Entera, Evgen, Formosa, Genentech, Gilead, GSK, Kintor, Marinomed, Moderna, Novartis, Renibus, Rigel, Roche, Sosei, Sun, Transgene, Vicore, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Senzime.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adicet, Affimed, Alar, Aligos, Beigene, Eli Lilly, Genentech, Gilead, Impact, VBI, Vertex, Viiv, Viriom.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Aerpio, Aim, Alteogen, Apellis, Apollomics, Atea, Bharat, Brii, Can-Fite, Cerecor, Cytodyn, Glaxosmithkline, Immunitybio, Immutep, Innovation, Longeveron, Merck, Morphosys, Nantkwest, Ocugen, Ridgeback, Roche, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cognito Therapeutics, Icad.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Aeon, Biontech, Biovie, Canbridge, Clene, Edesa, Gannex, Graybug, Irlab, Metacrine, Molecular Partners, Novartis, Oncosynergy, Orca, Oryzon, Pfizer, Rhovac, Rocket, Sagimet, TG, VBI, Xenon.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Exosome Diagnostics, Nanomedic.